Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00555501PMID 2905989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential effects of timolol and metoprolol on platelet function at rest and during exercise

  2004cited by this paper
• Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients

  2004cited by this paper
• Platelet alpha-adrenoceptor function and aging.

  1987cited by this paper
• Aging and platelet β-adrenoceptor function

  1987cited by this paper
• Aging and platelet beta-adrenoceptor function.

  1987cited by this paper
• Increased occurrence of left ventricular thrombi during early treatment with timolol in patients with acute myocardial infarction.

  1987cited by this paper
• A Comparative Study of the Effects of Adrenoceptor Antagonists on Platelet Aggregation and Thromboxane Generation

  1985cited by this paper
• Characterization of human platelet beta-adrenoceptors.

  1985cited by this paper
• Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.

  1984cited by this paper
• Intrinsic sympathomimetic activity: clinical fact or fiction?

  1983cited by this paper
• Platelet beta-adrenoceptors.

  1983cited by this paper
• Pindolol: A New β-Adrenoceptor Antagonist with Partial Agonist Activity

  1983cited by this paper
• Platelet β‐adrenoceptors

  1983cited by this paper
• Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity.

  1983cited by this paper
• Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion.

  1983cited by this paper
• Demonstration of human platelet beta-adrenergic receptors using 125I-labeled cyanopindolol and 125I-labeled hydroxybenzylpindolol.

  1982cited by this paper
• Comparison of four different beta-adrenoceptor blocking drugs on lymphocyte isoprenaline-stimulated cyclic AMP production.

  1981cited by this paper
• Anti-platelet activity of beta-adrenergic antagonists: inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment.

  1981cited by this paper
• Partial agonist activity of practolol on human lymphocyte cyclic AMP production.

  1981cited by this paper
• beta-Adrenoceptor antagonists: new drugs and new indications.

  1981cited by this paper
• β-Adrenoceptor Antagonists: New Drugs and New Indications

  1981cited by this paper
• Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.

  1978cited by this paper
• Cyclic AMP, adrenaline and noradrenaline in plasma during surgery

  1978cited by this paper
• Characterization of α- and β-adrenergic receptors linked to human platelet adenylate cyclase

  1978cited by this paper
• PLATELET HYPERAGGREGABILITY IN YOUNG PATIENTS WITH COMPLETED STROKE

  1977cited by this paper
• CIRCULATING INTERFERON AFTER TRANSFER-FACTOR THERAPY

  1973cited by this paper
• The use of non-parametric methods in the statistical analysis of the two-period change-over design.

  1972cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper

• Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise

  2019cites this paper
• Platelets and Hemostasis

  2018cites this paper
• Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.

  2017cites this paper
• Hypertension as a Risk Factor for Aspirin and Clopidogrel Resistance in Patients With Stable Coronary Artery Disease

  2014cites this paper
• Effect of β‐blockers on platelet aggregation: a systematic review and meta‐analysis

  2014cites this paper
• View and Perspective Migraine : Possible Role of Shear-Induced Platelet Aggregation With Serotonin

  2012cites this paper
• Migraine: Possible Role of Shear‐Induced Platelet Aggregation With Serotonin Release

  2012cites this paper
• БЕТА-АДРЕНОБЛОКАТОРЫ И АГРЕГАЦИЯ ТРОМБОЦИТОВ. КАРВЕДИЛОЛ

  2008cites this paper
• Aspirin resistance.

  2007cites this paper
• Differential associations of beta‐blockers with hemorrhagic events for chronic heart failure patients on warfarin

  2006cites this paper
• Transregulation of the α2-Adrenergic Signal Transduction Pathway by Chronic β-Blockade: A Novel Mechanism for Decreased Platelet Aggregation in Patients

  2005influential citation
• Effects of Stress and 3-Blockade on Platelet Function

  2005cites this paper
• Carane derivative stereoisomers of different local anaesthetic and antiplatelet activity similarly potentiate forskolin‐stimulated cyclic AMP response and bind to β‐adrenoceptors in the rat brain cortex

  2004cites this paper
• Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation

  2004cites this paper
• Platelet function and fibrinolytic activity in borderline and mild hypertension. The influence of age, exercise, smoking and antihypertensive therapy.

  2002cites this paper
• Antiplatelet activity of semotiadil fumarate.

  2002cites this paper
• Cerebral consequences of hypertension: where do they lead?

  1996cites this paper
• Effect of Spirapril and Hydrochlorothiazide on Platelet Function and Euglobulin Clot Lysis Time in Patients with Mild Hypertension

  1996cites this paper
• Role of catecholamines in platelet function: pathophysiological and clinical significance

  1996cites this paper
• The role of platelets in essential hypertension.

  1995cites this paper
• The effect of (—)‐4‐(2‐hydroxy‐3(N‐isopropylamino)‐propoxyimino)‐cis‐carane on basal and forskolin‐stimulated accumulation of cyclic AMP in the cerebral cortical slices of the rat

  1994cites this paper
• Effects of lisinopril and hydrochlorothiazide on platelet function and blood rheology in essential hypertension: a randomly allocated double-blind study

  1993cites this paper
• Haemodynamics and tissue specificity with isradipine

  1993cites this paper
• The effect of short-term celiprolol therapy on platelet function in essential hypertension.

  1993cites this paper
• Dose-response aggregometry--contribution to the precise platelet function evaluation.

  1992cites this paper
• Platelet activation and prostacyclin release in essential hypertension.

  1992cites this paper
• The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension

  1992cites this paper
• Enhanced Risk of Thromboembolic Disease in Hypertension from Platelet Hyperfunction and Decreased Fibrinolytic Activity: Has Antihypertensive Therapy Any Influence?

  1992cites this paper
• [Beta-blockaders and atheroma regression: a necessary evaluation?].

  1992cites this paper
• Platelet Function and Fibrinolytic Activity in Hypertension: Differential Effects of Calcium Antagonists and β‐Adrenergic Receptor Blockers

  1991cites this paper
• Effects of stress and beta-blockade on platelet function.

  1991cites this paper
• Platelet beta-adrenoceptor function. Experimental and clinical studies with special reference to age and stress.

  1991cites this paper
• Does Antihypertensive Therapy Affect the Natural Protection Against Thrombosis?

  1991cites this paper
• Effects of bopindolol on platelet function in hypertension at rest and during exercise.

  1990cites this paper
• Role of beta-adrenergic blockers after percutaneous transluminal coronary angioplasty.

  1990cites this paper
• Differential effects of non-specific beta-blockade and calcium antagonism on blood-clotting mechanisms.

  1989cites this paper